Tag: Parkinson’s
Phone-Based Therapy Beneficial for Depression in Parkinson Disease
Telephone CBT outperformed treatment-as-usual on all depression, anxiety, quality-of-life measures
Isradipine Does Not Slow Early Parkinson Disease Progression
Change in total Unified Parkinson's Disease Rating Scale score similar for isradipine versus placebo
Ophthalmologic Symptoms Common in Parkinson Disease
Sixty-eight percent of patients have ophthalmologic symptoms that interfere with daily activities
Active Lifestyle May Lower Risk for Parkinson Disease
Authors say finding may be explained by a motor reserve
Outpatient Palliative Care Improves Parkinson Outcomes
Additionally, some benefit is seen for certain caregiver measures
Road Proximity Linked to Incidence of Neurologic Diseases
Incidence increased for non-Alzheimer dementia, Parkinson, Alzheimer disease, multiple sclerosis
SAE Rate Higher With Nilotinib Versus Placebo in Parkinson Disease
Exploratory biomarkers altered in response to nilotinib, including drop in hyperphosphorylated tau
Antibiotic Exposure May Be Tied to Risk for Parkinson Disease
Link between exposure and diagnosis may be due to disruption of gut microbiota, authors say
Bipolar Disorder May Increase Risk for Developing Parkinson Disease
Literature review shows increased likelihood of idiopathic PD with previous diagnosis of BD
Cerebrovascular Risk Factors May Up Risk for Parkinson Disease
Most cerebrovascular risk factors linked to higher risk for subsequent diagnosis of Parkinson disease
